Skip to main content
. 2016 Oct 6;7(47):77117–77123. doi: 10.18632/oncotarget.12489

Table 2. Candidate SNPs tested in the study.

SNP ID Genes Band Role Alleles A/B p-HWE pa OR(95% CI)
rs275651 AGTR1 3q24 Promoter A/T 0.647 0.017* 0.65(0.45-0.93)
rs275652 AGTR1 3q24 Promoter G/T 0.647 0.016* 0.64(0.45-0.92)
rs2638360 AGTR1 3q24 Intron G/A 0.042 0.178 0.75(0.49-1.14)
rs4681443 AGTR1 3q24 Intron A/G 0.216 0.950 0.99(0.63-1.54)
rs1492099 AGTR1 3q24 Intron G/A 0.723 0.931 0.99(0.74-1.32)
rs1492097 AGTR1 3q24 Intron A/G 1.000 0.118 1.31(0.93-1.85)
rs4524238 AGTR1 3q24 Intron A/G 1.000 0.100 1.33(0.95-1.88)

SNP, single-nucleotide polymorphism; OR, odds ratio; 95%CI, 95% confidence interval; HWE, Hardy–Weinberg equilibrium.

a

Two-sided χ2 tests/Fisher's exact tests.

*

p ≤ 0.05 indicates statistical significance.